7 de diciembre de 2015 / 20:09 / en 2 años

BTG Pactual-backed BR Pharma says to move ahead with capital plan

SAO PAULO, Dec 7 (Reuters) - Brasil Pharma SA, the Brazilian drugstore chain backed by embattled investment bank Grupo BTG Pactual SA, is going ahead with a plan to raise as much as 600 million reais ($160 million) from investors, the company told Reuters on Monday.

In a statement, BR Pharma, as the company is commonly known, said that it “is sticking to the planned offering and is currently working on it,” declining to elaborate.

The capital plan, which set a floor of 400 million reais, could be launched formally as early as this week, when executives at São Paulo-based BR Pharma will meet investors in so-called road show meetings, according to a source who requested anonymity since the plan remains private.

($1 = 3.769082 Brazilian reais)

Reporting by Tatiana Bautzer and Paula Arend Laier; Editing by Guillermo Parra-Bernal and Tom Brown

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below